These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34275336)

  • 1. Detection of Nonadherence to Antihypertensive Treatment by Measurements of Serum Drug Concentrations.
    Bergland OU; Halvorsen LV; Søraas CL; Hjørnholm U; Kjær VN; Rognstad S; Brobak KM; Aune A; Olsen E; Fauchald YM; Heimark S; Thorstensen CW; Liestøl K; Solbu MD; Gerdts E; Mo R; Rostrup M; Kjeldsen SE; Høieggen A; Opdal MS; Larstorp ACK; Fadl Elmula FEM
    Hypertension; 2021 Sep; 78(3):617-628. PubMed ID: 34275336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of adherence to treatment in patients with resistant hypertension using toxicological serum analysis. A subgroup evaluation of the RESIST-POL study.
    Florczak E; Tokarczyk B; Warchoł-Celińska E; Szwench-Pietrasz E; Prejbisz A; Gosk M; Kabat M; Narkiewicz K; Januszewicz A; Kała M
    Pol Arch Med Wewn; 2015; 125(1-2):65-72. PubMed ID: 25578261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication adherence in patients with apparent resistant hypertension: findings from the SYMPATHY trial.
    de Jager RL; van Maarseveen EM; Bots ML; Blankestijn PJ;
    Br J Clin Pharmacol; 2018 Jan; 84(1):18-24. PubMed ID: 28815689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical Screening for Nonadherence Is Associated With Blood Pressure Reduction and Improvement in Adherence.
    Gupta P; Patel P; Štrauch B; Lai FY; Akbarov A; Gulsin GS; Beech A; Marešová V; Topham PS; Stanley A; Thurston H; Smith PR; Horne R; Widimský J; Keavney B; Heagerty A; Samani NJ; Williams B; Tomaszewski M
    Hypertension; 2017 Nov; 70(5):1042-1048. PubMed ID: 28847892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence.
    Avataneo V; De Nicolò A; Rabbia F; Perlo E; Burrello J; Berra E; Pappaccogli M; Cusato J; D'Avolio A; Di Perri G; Veglio F
    Br J Clin Pharmacol; 2018 Nov; 84(11):2535-2543. PubMed ID: 29971815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.
    Ewen S; Meyer MR; Cremers B; Laufs U; Helfer AG; Linz D; Kindermann I; Ukena C; Burnier M; Wagenpfeil S; Maurer HH; Böhm M; Mahfoud F
    Clin Res Cardiol; 2015 Dec; 104(12):1097-105. PubMed ID: 26306594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring Antihypertensive Medication Adherence by Liquid Chromatography-Tandem Mass Spectrometry: Method Establishment and Clinical Application.
    Wang Y; Wang JW; Wang Y; Yang B; Yinghua Du A; Kong Z; Chen M; Wang J
    J Cardiovasc Pharmacol; 2021 Oct; 78(4):581-596. PubMed ID: 34269698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine urinary detection of antihypertensive drugs for systematic evaluation of adherence to treatment in hypertensive patients.
    Hamdidouche I; Jullien V; Boutouyrie P; Billaud E; Azizi M; Laurent S
    J Hypertens; 2017 Sep; 35(9):1891-1898. PubMed ID: 28505066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis.
    Tomaszewski M; White C; Patel P; Masca N; Damani R; Hepworth J; Samani NJ; Gupta P; Madira W; Stanley A; Williams B
    Heart; 2014 Jun; 100(11):855-61. PubMed ID: 24694797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for non-adherence to antihypertensive treatment as a part of the diagnostic pathway to renal denervation.
    Patel P; Gupta PK; White CM; Stanley AG; Williams B; Tomaszewski M
    J Hum Hypertens; 2016 Jun; 30(6):368-73. PubMed ID: 26446393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonadherence to antihypertensive medications is related to pill burden in apparent treatment-resistant hypertensive individuals.
    Lawson AJ; Hameed MA; Brown R; Cappuccio FP; George S; Hinton T; Kapil V; Lenart J; Lobo MD; Martin U; Menon M; Nightingale A; Rylance PB; Webb DJ; Dasgupta I
    J Hypertens; 2020 Jun; 38(6):1165-1173. PubMed ID: 32371807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliable and easy-to-use LC-MS/MS-method for simultaneous determination of the antihypertensives metoprolol, amlodipine, canrenone and hydrochlorothiazide in patients with therapy-refractory arterial hypertension.
    Johannsen JO; Reuter H; Hoffmann F; Blaich C; Wiesen MHJ; Streichert T; Müller C
    J Pharm Biomed Anal; 2019 Feb; 164():373-381. PubMed ID: 30439665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing Adherence to Antihypertensive Medication by Means of Dose-Dependent Reference Plasma Concentration Ranges and Ultra-High Performance Liquid Chromatography-Ion Trap Mass Spectrometry Analysis.
    Wagmann L; Vollmer AC; Lauder L; Mahfoud F; Meyer MR
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33803489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug nonadherence is a common but often overlooked cause of hypertensive urgency and emergency at the emergency department.
    Overgaauw N; Alsma J; Brink A; Hameli E; Bahmany S; Peeters LEJ; Van Den Meiracker AH; Schuit SCE; Koch BCP; Versmissen J
    J Hypertens; 2019 May; 37(5):1048-1057. PubMed ID: 30480568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy.
    Ceral J; Habrdova V; Vorisek V; Bima M; Pelouch R; Solar M
    Hypertens Res; 2011 Jan; 34(1):87-90. PubMed ID: 20882030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Nonadherence to Antihypertensive Treatment.
    Gupta P; Patel P; Štrauch B; Lai FY; Akbarov A; Marešová V; White CMJ; Petrák O; Gulsin GS; Patel V; Rosa J; Cole R; Zelinka T; Holaj R; Kinnell A; Smith PR; Thompson JR; Squire I; Widimský J; Samani NJ; Williams B; Tomaszewski M
    Hypertension; 2017 Jun; 69(6):1113-1120. PubMed ID: 28461599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Drug Monitoring to Assess Drug Adherence in Assumed Resistant Hypertension: A Comparison With Directly Observed Therapy in Three Nonadherent Patients.
    Šíma M; Slanař O
    J Cardiovasc Pharmacol; 2019 Feb; 73(2):125. PubMed ID: 30531438
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug adherence in treatment resistant and in controlled hypertension-Results from the Swedish Primary Care Cardiovascular Database (SPCCD).
    Holmqvist L; Boström KB; Kahan T; Schiöler L; Qvarnström M; Wettermark B; Hjerpe P; Hasselström J; Manhem K
    Pharmacoepidemiol Drug Saf; 2018 Mar; 27(3):315-321. PubMed ID: 29349834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of a Smartphone Application With Medication Adherence and Blood Pressure Control: The MedISAFE-BP Randomized Clinical Trial.
    Morawski K; Ghazinouri R; Krumme A; Lauffenburger JC; Lu Z; Durfee E; Oley L; Lee J; Mohta N; Haff N; Juusola JL; Choudhry NK
    JAMA Intern Med; 2018 Jun; 178(6):802-809. PubMed ID: 29710289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive medication adherence and blood pressure control among central Alabama veterans.
    Piercefield EW; Howard ME; Robinson MH; Kirk CE; Ragan AP; Reese SD
    J Clin Hypertens (Greenwich); 2017 May; 19(5):543-549. PubMed ID: 27917605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.